CollPlant · raw details

Products and Technologies for Regenerative and Aesthetic Medicine · Rehovot · Founded 2004

active Mature ← back to profile

Highlights

Profile claimed by owner

About

Products and Technologies for Regenerative and Aesthetic Medicine

CollPlant is a regenerative and aesthetic medicine company developing technologies and products for tissue regeneration and organ manufacturing.

Its revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, CollPlant is developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

Identity

NameCollPlant
Slugcollplant
Former namesCollPlant Holdings Ltd
Type / kindstartup
Crunchbase IDcollplant
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7q_YkLDA

Status

Statusactive
Status reasonPublic on NASDAQ on Dec 2010;
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityRehovot
HQ addressProf. Hillel ve-Khanan Oppenheimer St 4, Rehovot, Israel

Web & social

Websitehttps://collplant.com
LinkedInhttps://www.linkedin.com/company/2369898
Twitter / Xhttps://twitter.com/CollplantBio
Facebookhttps://www.facebook.com/CollPlantBio
YouTubehttps://www.youtube.com/channel/UC_7SlEx2hGdrw75fvVeOgsw

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenesMachinery & Robotics3D Printing & Additive Manufacturing
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business models
B2B
Tags
orthopedicsregenerative-medicinebiomaterialstissue-regenerationpharmaceuticalstreatmentsmedical-devicesnanotechnology3d-technologydrug-deliverymedical-productsmedical-technologies

Funding

Total raised$91.0M
Current stageMature
Market cap$17.9M

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}